Abstract
Session presented on Saturday, July 23, 2016 and Sunday, July 24, 2016:
Purpose: Infection with human immunodeficiency virus (HIV) has been identified as the strongest risk factor in the reactivation of latent or new Mycobacterium tuberculosis infection to active TB disease. TB is also the commonest cause of morbidity and mortality among the HIV-infected population in South Africa and studies have shown that TB accelerates HIV disease progression. Isoniazid preventive therapy (IPT) is one of the interventions recommended by the WHO and the South African NDOH for the prevention of progression to active TB disease in people living with HIV (PLHIV). The aim of the study was to describe the incidence of TB amongst HIV-positive clients who received IPT in a Primary Health Care Clinic and to identify the factors assosiated with defaulting.
Methods: Quantitative non-experimental descriptive retrospective cohort study was undertaken to ascertain the incidence of tuberculosis among adult HIV positive clients who received IPT. 104 clinic records of HIV positive adult clients accessing care at a Clinic in South Africa who were commenced on IPT between 01 July 2010 and 30 November 2011 were analysed.
Results: The study findings revieled that 66 of 104 (63.5%) study respondents completed the course of IPT and the majority of those that defaulted were due to poor quality of care. Gender was statistically found to have played a role on whether a patient completes IPT. None of the study respondents that completed IPT was diagnosed with TB disease.
Conclusion: It remains a serious concern that inadequacies or incompetence of healthcare providers were the main reasons for defaulting Isoniazid Preventive Therapy as isoniazid was not dispensed to the patients, despite the evidence of the effectiveness of the therapy as none of the patients who completed the course of IPT contracted active TB disease during the duration of the study. Intervention strategies to improve uptake of IPT must be advocated. The findings should benefit policy makers, healthcare professionals, and particularly the patients in need.
Sigma Membership
Tau Lambda at-Large
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Antiretroviral Therapy, Isoniazid Preventive Therapy, Tuberculosis
Recommended Citation
Roets, Lizeth and Okoli, Emmanuel Ikechukwu, "Isoniazid preventive therapy (IPT) defaulting: Who are responsible?" (2016). INRC (Congress). 100.
https://www.sigmarepository.org/inrc/2016/posters_2016/100
Conference Name
27th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Cape Town, South Africa
Conference Year
2016
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Isoniazid preventive therapy (IPT) defaulting: Who are responsible?
Cape Town, South Africa
Session presented on Saturday, July 23, 2016 and Sunday, July 24, 2016:
Purpose: Infection with human immunodeficiency virus (HIV) has been identified as the strongest risk factor in the reactivation of latent or new Mycobacterium tuberculosis infection to active TB disease. TB is also the commonest cause of morbidity and mortality among the HIV-infected population in South Africa and studies have shown that TB accelerates HIV disease progression. Isoniazid preventive therapy (IPT) is one of the interventions recommended by the WHO and the South African NDOH for the prevention of progression to active TB disease in people living with HIV (PLHIV). The aim of the study was to describe the incidence of TB amongst HIV-positive clients who received IPT in a Primary Health Care Clinic and to identify the factors assosiated with defaulting.
Methods: Quantitative non-experimental descriptive retrospective cohort study was undertaken to ascertain the incidence of tuberculosis among adult HIV positive clients who received IPT. 104 clinic records of HIV positive adult clients accessing care at a Clinic in South Africa who were commenced on IPT between 01 July 2010 and 30 November 2011 were analysed.
Results: The study findings revieled that 66 of 104 (63.5%) study respondents completed the course of IPT and the majority of those that defaulted were due to poor quality of care. Gender was statistically found to have played a role on whether a patient completes IPT. None of the study respondents that completed IPT was diagnosed with TB disease.
Conclusion: It remains a serious concern that inadequacies or incompetence of healthcare providers were the main reasons for defaulting Isoniazid Preventive Therapy as isoniazid was not dispensed to the patients, despite the evidence of the effectiveness of the therapy as none of the patients who completed the course of IPT contracted active TB disease during the duration of the study. Intervention strategies to improve uptake of IPT must be advocated. The findings should benefit policy makers, healthcare professionals, and particularly the patients in need.